日研究人员用转基因猪探究糖尿病及并发症

2017-05-31 佚名 健康报

日本研究人员日前利用转基因技术在猪身上再现了糖尿病及视网膜病和肾衰竭等并发症。在大型哺乳动物身上再现这些疾病,将有助于研究引起并发症的机制及相应的治疗方法。

日本研究人员日前利用转基因技术在猪身上再现了糖尿病及视网膜病和肾衰竭等并发症。在大型哺乳动物身上再现这些疾病,将有助于研究引起并发症的机制及相应的治疗方法。

据《日本经济新闻》5月29日报道,人体内可降低血糖值的胰岛素分泌不足会导致糖尿病。高血糖使血管和神经受损从而产生并发症,严重时会导致失明或肾衰竭等。

日本明治大学的一个研究小组利用最新的基因工程技术给猪转入了引发人类糖尿病的基因,使猪的胰岛素分泌减少并患上糖尿病。通过长期饲养观察发现,患病猪的血管也变得脆弱;视网膜出血症状不断加重,还出现了白内障;肾脏也出现了衰竭症状。

此前由于实验鼠的体重和寿命都和人类有较大差异,因此药物研发效果不如利用猪这类脏器大小和血糖值等与人类接近的哺乳动物。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2037459, encodeId=c4bf203e45990, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Thu Jun 15 18:48:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757792, encodeId=0ac21e5779223, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sun Jul 02 13:48:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907481, encodeId=bc25190e481a0, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jul 15 05:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471913, encodeId=a8c914e19138f, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555249, encodeId=832d155524936, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2037459, encodeId=c4bf203e45990, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Thu Jun 15 18:48:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757792, encodeId=0ac21e5779223, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sun Jul 02 13:48:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907481, encodeId=bc25190e481a0, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jul 15 05:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471913, encodeId=a8c914e19138f, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555249, encodeId=832d155524936, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=)]
    2017-07-02 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=2037459, encodeId=c4bf203e45990, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Thu Jun 15 18:48:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757792, encodeId=0ac21e5779223, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sun Jul 02 13:48:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907481, encodeId=bc25190e481a0, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jul 15 05:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471913, encodeId=a8c914e19138f, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555249, encodeId=832d155524936, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2037459, encodeId=c4bf203e45990, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Thu Jun 15 18:48:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757792, encodeId=0ac21e5779223, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sun Jul 02 13:48:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907481, encodeId=bc25190e481a0, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jul 15 05:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471913, encodeId=a8c914e19138f, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555249, encodeId=832d155524936, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2037459, encodeId=c4bf203e45990, content=<a href='/topic/show?id=2d85933231f' target=_blank style='color:#2F92EE;'>#转基因猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93323, encryptionId=2d85933231f, topicName=转基因猪)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/DC48AC6B5FFD609EED5594C15A97B420/100, createdBy=57dc2500034, createdName=ms1692212821629096, createdTime=Thu Jun 15 18:48:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757792, encodeId=0ac21e5779223, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sun Jul 02 13:48:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907481, encodeId=bc25190e481a0, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jul 15 05:48:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471913, encodeId=a8c914e19138f, content=<a href='/topic/show?id=e97a93305ec' target=_blank style='color:#2F92EE;'>#转基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93305, encryptionId=e97a93305ec, topicName=转基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76227191338, createdName=旅苦化文_210, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555249, encodeId=832d155524936, content=<a href='/topic/show?id=f367681e434' target=_blank style='color:#2F92EE;'>#猪#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68174, encryptionId=f367681e434, topicName=猪)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ec214601917, createdName=muzishouyi, createdTime=Fri Jun 02 02:48:00 CST 2017, time=2017-06-02, status=1, ipAttribution=)]
    2017-06-02 muzishouyi

相关资讯

大连化物所利用器官芯片技术构建糖尿病肾病模型

大连化物所利用器官芯片技术构建糖尿病肾病模型近日,中国科学院大连化学物理研究所研究员秦建华领导的微流控芯片研究团队利用器官芯片技术成功构建了一种功能化肾芯片系统,并用于模拟糖尿病肾病早期病理变化,相关研究成果发表在 Lab on a Chip(2017,17(10):1749-1760) 杂志上。糖尿病肾病是糖尿病的常见并发症之一,也是导致慢性肾功能衰竭的主要原因,其早期肾脏损害主要表现为

Hypertension:β受体阻滞剂对糖尿病患者心血管事件的影响!

总之,在糖尿病患者中应用β-受体阻滞剂与心血管事件风险增加相关。

发现糖尿病患者患痴呆、认知减退的重要风险因素

根据 5 月 12 日发表在《糖尿病护理》上的最新研究,糖尿病患者的血糖峰值水平与认知衰退和痴呆有关。糖化血红蛋白(HbAlc)是反应血糖水平一个重要指标,它与患痴呆和认知功能的损伤有关。然而血糖变异性和葡萄糖偏差在这种联系中所起到的作用还不明确。来自巴尔的摩约翰霍普金斯大学彭博公共卫生学院的 Andreea M. Rawlings 及其同事在近 13,000 名参与了动脉粥样硬化社区风险

JCEM:血红蛋白指数与糖代谢异常患者的心血管疾病风险相关

糖化血红蛋白(glycated hemoglobin,HbA1c)和血浆葡萄糖浓度之间的联系有大量的个体间差异。目前,这些差异对心血管疾病(CVD)的影响没有被全面评估过。因此,研究人员进行了本研究,以研究糖化血红蛋白(与血红蛋白指数[HGI]相关)的个体差异和心血管疾病之间的关联。研究人员对1248名首次接受糖尿病前期或糖尿病的患者进行了横截面分析。HGI被定义为测量糖化血红蛋白 - 通过HbA

AMT:高灵敏度基于铂纳米颗粒修饰栅极的有机电化学晶体管应用于生物代谢物检测

糖尿病是一种以高血糖为特征的代谢性疾病,目前已经成为威胁人类健康的最重要的慢性病之一。根据国际糖尿病联合会的统计,截止2013年,全球糖尿病患者已达3.82亿人,并有3.16亿糖尿病高危人群。与此同时,糖尿病的发病越来越趋向于低龄化并且重心开始转向发展中国家。传统的依赖于血糖仪和血糖试纸的糖尿病检测方式属于侵入性检测,不仅会给患者带来疼痛而且会有感染的风险,因此,开发一种便宜的,便于日常使用的非侵

食药监总局提醒:糖尿病等疾病患者一定要控制粽子食用量

一年一度的中国传统节日——端午节即将到来,在节日期间,粽子将成为节日饮食中不可或缺的一种美食,那么在选购、烹饪、储存和食用粽子等环节需要注意哪些事项?一、选择正规渠道购买具有清晰标识的粽子产品。消费者在选购粽子时应从正规渠道购买。挑选时,真空包装粽子、塑料袋或铝箔袋粽子包装应完好,要注意观察包装袋是否有破损、漏气或涨袋等现象。粽子的尖角容易刺破软包装材料,一旦破损,易造成细菌侵入从而引起粽子变质。